Skip to main content
. 2015 Apr 27;10(4):e0124169. doi: 10.1371/journal.pone.0124169

Table 7. Comparison of the QOL-ACD total score for each subscale according to the presence or absence of individual adverse events.

Adverse events Grade n Total score
Before CT (A) After CT (B) Difference (B-A) p
Alopecia 0.649
0 16 86.25±13.91 83.31±16.20 -2.94±11.01
1–3 31 89.74±9.40 85.23±12.96 -4.52±11.28
Nail ridging 0.671
0 42 88.17±11.48 84.43±14.27 -3.74±11.40
1–3 5 91.80±7.43 85.80±12.85 -6.00±8.80
Dry skin 0.795
0 40 88.83±10.89 85.03±14.19 -3.80±11.85
1–3 7 87.00±13.14 82.00±13.60 -5.00±5.35
Nausea 0.123
0 35 87.63±10.88 85.11±15.08 -2.51±11.82
1–3 12 91.25±11.84 83.00±10.62 -8.25±7.48
Constipation 0.675
0 31 89.26±12.55 85.77±13.65 -3.48±10.02
1–3 16 87.19±7.78 82.25±14.82 -4.94±13.23
Mucositis oral 0.885
0 35 88.54±10.60 84.46±14.38 -4.09±12.30
1–3 12 88.58±13.01 84.92±13.43 -3.67±6.84
Oral pain 0.309
0 42 88.62±11.36 85.21±14.09 -3.41±11.52
1–3 5 88.00±9.82 79.20±13.37 -8.80±4.82
Peripheral sensory neuropathy 0.376
0 38 89.13±11.53 84.45±13.88 -4.68±11.05
1–3 9 86.11±9.36 85.11±15.34 -1.00±11.42
Dysgeusia 0.123
0 39 87.54±11.42 84.69±14.97 -2.85±11.49
1–3 8 93.50±8.37 84.00±8.45 -9.50±7.03
Malaise 0.456
0 21 89.10±12.91 86.48±14.74 -2.62±9.99
1–3 26 88.12±9.67 83.04±13.46 -5.08±11.99
Fever 0.075
0 40 87.48±11.39 84.70±14.34 -2.78±10.98
1–3 7 94.71±7.16 83.86±12.82 -10.86±9.75
White blood cell decreased 0.229
0 37 88.81±11.84 83.81±15.23 -5.00±11.22
1–3 10 87.60±8.32 87.40±7.95 -0.20±10.26
Anemia 0.481
0 29 89.10±11.75 86.03±14.64 -3.07±10.69
1–3 18 87.67±10.26 82.22±12.95 -5.44±11.87
Anorexia <0.001 *
0 27 86.40±11.76 87.48±14.65 1.07±10.25
1–3 20 91.45±9.71 80.65±12.35 -10.80±8.29

CT: chemotherapy, mean±standard deviation,

*p<0.05